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nfection with murine cytomegalovirus (MCMV) has
contributed to understanding many aspects of human
infection and, additionally, has provided important insight
to understanding complex cellular responses. Dendritic
cells (DCs) are a major target for MCMV infection. Here, we
analyze the effects of MCMV infection on DC viability, and
show that infected DCs become resistant to apoptosis induced
by growth factor deprivation. The precise contribution of
changes in the expression of Bcl-2 family proteins has been
assessed and a new checkpoint in the apoptotic pathway
I
 
identiﬁed. Despite their resistance to apoptosis, MCMV-
infected DCs showed Bax to be tightly associated with mito-
chondria and, together with Bak, forming high molecular
weight oligomers, changes normally associated with apop-
totic cell death. Exposure of a constitutively occluded Bax
NH
 
2
 
-terminal epitope was blocked after infection. These
results suggest that MCMV has evolved a novel strategy for
inhibiting apoptosis and provide evidence that apoptosis
can be regulated after translocation, integration, and oligo-
merization of Bax at the mitochondrial membrane.
 
Introduction
 
Apoptosis is a highly regulated control process involving
the removal of damaged or unwanted cells from multicellular
organisms. Elimination of infected cells through a process
of rigorously controlled cell death provides a powerful
defense mechanism against intracellular pathogens, such as
viruses. Not surprisingly, viruses have evolved strategies to
modulate apoptosis, and thereby circumvent host immune
defense (Roulston et al., 1999). The relevance of apoptosis
in the control of viral replication is demonstrated by the
known antiviral effects of agents that trigger apoptosis,
such as TNF and Fas ligand, and by the identification of
viral proteins with anti-apoptotic activity (Xu et al., 2001).
In particular, large DNA viruses, such as baculovirus, adeno-
virus, pox viruses, and herpes viruses, encode a number of
proteins that interfere at various stages of the apoptotic
pathway (Roulston et al., 1999; Tortorella et al., 2000).
Cytomegalovirus (CMV), a member of the 
 
  
 
herpes virus
family, is a prime candidate for possessing anti-apoptotic
functions, because its replication cycle is relatively slow and
the virus persists lifelong within its host (Mocarski, 1996).
Previously, infection of human umbilical-vein endothelial or
mouse neuronal cells with human CMV (HCMV) and murine
CMV (MCMV), respectively, was found to render infected
cells resistant to apoptosis (Kovacs et al., 1996; Kosugi et al.,
1998; Wang et al., 2000). Unlike other herpes viruses, CMV
does not encode homologues of Bcl-2 or FLIP (Roulston et
al., 1999). Anti-apoptotic properties have been ascribed to the
M45 gene of MCMV, and the UL36 and UL37 genes of
HCMV (Goldmacher et al., 1999; Brune et al., 2001;
Skaletskaya et al., 2001). Although the mechanism of action
for M45 is unknown, UL36 appears to act by inhibiting
caspase-8 activation, and UL37 prevents mitochondrial per-
meabilization (Goldmacher et al., 1999; Skaletskaya et al.,
2001). Despite having ascribed anti-apoptotic activities to
several CMV proteins, the precise checkpoints targeted by the
virus in apoptotic pathways have not been defined.
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Central to apoptotic pathways is the action of caspases, a
group of aspartate-specific cysteine proteases whose activa-
tion is regulated by the Bcl-2 family of proteins (Cory and
Adams, 2002; Shi, 2002). The Bcl-2 family is composed of
both pro- and anti-apoptotic proteins that share homology
in the Bcl-2 homology (BH) regions (Marsden and Strasser,
2003). The current paradigm suggests that pro-survival Bcl-2
family proteins prevent caspase activation by maintaining
mitochondrial integrity (Gross et al., 1999). The activity of
pro-survival Bcl-2 proteins is counteracted by two groups of
pro-apoptotic proteins, namely, Bax/Bak and the BH3-only
group of proteins. BH3-only proteins are regulated by a va-
riety of mechanisms, such as sequestration to the cytoskele-
ton, which favorably positions these molecules to act as sen-
sors for apoptotic stimuli (Puthalakath and Strasser, 2002).
In response to apoptotic stimuli, BH3-only proteins translo-
cate to the mitochondria where it appears they antagonize
the function of pro-survival Bcl-2 proteins (Puthalakath and
Strasser, 2002).
The BH3-only proteins require the presence of the Bax/
Bak proteins for killing. Bax, normally a monomer located
in the cytoplasm, undergoes a conformational change,
translocates to the mitochondria, and oligomerizes once
activated (Hsu et al., 1997; Wolter et al., 1997). Similarly,
apoptotic stress results in conformational changes and oli-
gomerization of Bak, although Bak is constitutively local-
ized to mitochondria (Griffiths et al., 1999; Nechushtan
et al., 2001). Activation of Bax/Bak at mitochondria is
thought to induce permeabilization of the outer mitochon-
drial membrane, thereby allowing the release of pro-apop-
totic proteins, such as cytochrome 
 
c
 
 and Smac/DIABLO,
and the subsequent activation of caspases (Gross et al.,
1999). Retention of Bax in the cytoplasm most likely acts
as a safe guard against inappropriate activation of the cell
death machinery. Consistent with this theory is the obser-
vation that enforced dimerization of Bax induces apopto-
sis, and Bax mutants that are constitutively localized to mi-
tochondria are more effective killers (Gross et al., 1998;
Suzuki et al., 2000). However, cells exposed to the apopto-
sis inducing drug taxol were shown to survive despite the
fact that Bax dimerized and translocated to the mitochon-
dria (Makin et al., 2001). Furthermore, detachment of epi-
thelial cells from ECM resulted in reversible changes to
Bax conformation and localization (Gilmore et al., 2000;
Valentijn et al., 2003). These results suggest that activation
of Bax is not sufficient to commit to apoptosis, and that an
additional checkpoint may exist.
The ability of CMV to successfully escape immune re-
sponses and to establish persistent infection of its hosts led
us to hypothesize that this virus would be capable of inter-
fering with apoptosis in cells that are key immune effectors.
DCs are specialized antigen presenting cells critical for the
initiation and regulation of both innate and adaptive im-
mune responses (Banchereau et al., 2000). Our recent stud-
ies have identified DCs as a major target for MCMV infec-
tion, both in vivo and in vitro (Andrews et al., 2001). Here,
we have demonstrated that MCMV-infected DCs become
resistant to apoptosis. Furthermore, we have assessed the
precise contribution of changes in the expression of Bcl-2
family proteins and have defined the specific point at which
MCMV interferes in the apoptotic pathway. Our studies
provide evidence that translocation of Bax to mitochondria,
and oligomerization of Bax and Bak are not sufficient for the
initiation of apoptotic cell death.
 
Results
 
MCMV prevents apoptosis in DCs
 
Recently, we have demonstrated that DCs are permissive to
MCMV infection, and that infection results in functional
impairment of these cells (Andrews et al., 2001). To success-
fully replicate several viruses have evolved mechanisms to
prevent apoptosis of host cells (Tortorella et al., 2000). We
sought to determine whether MCMV affected the ability of
DCs to undergo apoptosis. The well-characterized D1 DC
culture system was initially used for these experiments be-
cause, unlike freshly isolated DCs which undergo spontane-
ous maturation and cell death, D1 cells maintain an imma-
ture DC phenotype and proliferate when grown in the
presence of growth factor enriched conditioned medium
(CM; Winzler et al., 1997). Removal of CM causes D1 cells
to undergo apoptosis (Rescigno et al., 1998). Hence, D1
DC cultures provide a unique system to study the effects of
MCMV infection on immature DCs, a cell type we have
shown to be a major target of MCMV infection in vivo (An-
drews et al., 2001).
Initially, we determined whether MCMV could prevent
apoptosis of D1 cells after growth factor withdrawal. D1
DCs were infected with MCMV at a multiplicity of infec-
tion (MOI) 
 
 
 
3 and cultured for 4 d, by which time 100%
of the cells are MCMV infected (Andrews et al., 2001).
MCMV-infected D1, and uninfected control D1 cells,
were washed and replated in either normal growth me-
dium or in medium lacking CM. After 16 h the number of
viable cells was determined by flow cytometry using an-
nexin V-FITC staining. Consistent with previous reports,
a significant decrease in the percentage of viable cells was
observed when CM was removed from DC cultures (Fig. 1
a; Rescigno et al., 1998). Conversely, withdrawal of CM
from DCs infected with MCMV did not affect cell viabil-
ity (Fig. 1 a).
Stimulation of D1 DCs with LPS induces functional mat-
uration, arrests DC proliferation, and promotes survival af-
ter growth factor deprivation (Winzler et al., 1997; Rescigno
et al., 1998). The effect of MCMV infection on DC viabil-
ity after growth factor withdrawal was compared with the ef-
fect of LPS-induced maturation. D1 cells were either in-
fected with MCMV (MOI 
 
 
 
3 for 4 d), activated with LPS
(10 
 
 
 
g/ml for 2 d), or left untreated. Cells were then re-
plated in the presence or absence of CM and the number of
viable cells determined (Fig. 1 b). LPS-stimulated D1 cells
were cell cycle arrested and became resistant to apoptosis in-
duced by growth factor withdrawal (Rescigno et al., 1998).
Infection of D1 cells with MCMV also resulted in cell cycle
arrest, and was as effective as LPS stimulation at protecting
against apoptosis (Fig. 1 b).
Although activation of caspases is considered a crucial effec-
tor of apoptosis, some evidence exists for a caspase-independent
apoptotic pathway (Marsden and Strasser, 2003). We exam-
ined whether caspases are activated during apoptosis of DCs. 
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Uninfected, LPS-stimulated, and MCMV-infected D1 DCs
were grown in the presence or absence of growth factor for 12 h
and total cell lysates prepared. Caspase activity in the lysates was
measured using a colorimetric substrate (Ac-DEVD-pA) for
caspase-3 and related caspases. After growth factor withdrawal
from uninfected immature D1 cells, a significant increase in
caspase activity was observed (Fig. 1 c). No change in caspase
activity was observed after growth factor removal from LPS-
stimulated or MCMV-infected cells (Fig. 1 c).
We then tested the effect of MCMV infection on the via-
bility of in vitro expanded DCs. These experiments were
performed using DCs generated from the bone marrow by
Flt3L expansion (Brasel et al., 2000). This method generates
cells with phenotypic and functional characteristics of DCs
found in lymphoid tissues (Brasel et al., 2000). After in vitro
expansion, DCs were infected with MCMV (MOI 
 
 
 
3) and
cultured in the presence of Flt3L for a further 4 d. MCMV-
infected DCs and uninfected control DCs were then washed
and replated in growth medium containing 10% FCS and
Flt3L or in medium containing 1% FCS only. The number
of viable cells was determined 16 h later by annexin V-FITC
staining. Removal of FCS and Flt3L resulted in a significant
reduction in the percentage of viable cells in the control cul-
tures (Fig. 1 d). No change in the viability of MCMV-infected
DCs was observed after withdrawal of FCS and Flt3L (Fig.
1 d). These studies, using bone marrow–derived DCs, con-
firmed that MCMV inhibits DC cell death.
 
MCMV-infected DCs are resistant to apoptosis induced 
by inhibition of PI3 kinase
 
Next we sought to determine which cellular signal transduc-
tion pathways are involved in protecting MCMV-infected
DCs from apoptosis. Activation of extracellular signal regu-
lated kinase (ERK) is required to maintain the viability of
LPS-stimulated DCs after growth factor withdrawal (Re-
scigno et al., 1998). However, inhibition of ERK does not
affect the viability of immature or LPS-stimulated DCs
grown in the presence of growth factors (Rescigno et al.,
1998). Similarly, inhibition of ERK kinases does not affect
the viability of freshly isolated splenic DCs or human mono-
cyte-derived DCs (Ardeshna et al., 2000; Park et al., 2002).
The protection from apoptosis provided by stimulation with
LPS or CpG DNA in these systems can be blocked after in-
hibition of the phosphatidylinositide-3-OH kinase (PI3 ki-
nase) pathway (Ardeshna et al., 2000; Park et al., 2002).
The role of PI3 kinase activity in the context of DC sur-
vival was tested using LY294002, a specific inhibitor of PI3
kinase. MCMV-infected D1, or uninfected control D1 cells,
were plated into fresh medium containing growth factor in
the absence or presence of 50 
 
 
 
M LY294002, and the per-
centage of viable cells determined by annexin V-FITC stain-
ing after 16 h. Incubation of D1 DCs with LY294002 lead to
reduced viability, suggesting that PI3 kinase activity is critical
for maintaining DC viability (Fig. 2 a). MCMV-infected
Figure 1. MCMV inhibits apoptosis in DCs. (a) The viability of D1 
DCs infected with MCMV (MOI  3) for 4 d was measured after culture 
in the presence or absence of growth factor CM for 16 h. Data 
represent mean   SD; n   6. (b) The viability of uninfected, MCMV-
infected or LPS-stimulated D1 DCs cultured in the presence or 
absence of CM for the indicated times was measured. Data represent 
mean   SD; n   6. (c) Caspase activity in uninfected, LPS-stimulated 
or MCMV-infected D1 DCs grown in the presence or absence of 
CM for 12 h was determined by cleavage of the caspase-3 substrate 
Ac-DEVD-pA. Data represent mean   SD; n   3. (d) Viability of 
Flt3L expanded MCMV-infected or control DCs cultured in medium 
containing 10% FCS and Flt3L (cells grown in CM), or 1% FCS (cells 
grown in the absence of CM). Data represent mean   SD; n   3. 
Shaded bars represent cells grown in CM. White bars represent cells 
grown in the absence of CM.
Figure 2. Inhibition of PI3 kinase does not affect the viability 
of MCMV-infected DCs. (a) Percentage viability of immature or 
MCMV-infected D1 DCs cultured in normal growth medium, medium 
containing 50  M LY 294002, or medium containing 10  M UO126 
for 16 h. (b) Viability of MCMV-infected, LPS-stimulated or control 
D1 DCs grown in medium containing 25  M LY 294002. Data 
presented in a and b represent mean   SD; n   6. Shaded bars 
represent uninfected immature DCs. White bars represent MCMV-
infected DCs. 
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DCs were found to be resistant to the effects of LY294002,
indicating that the virus can bypass the requirement for a sig-
nal from PI3 kinase in maintaining cell viability (Fig. 2 a).
The contribution of the ERK MAP kinase pathway to viabil-
ity was also assessed using the MEK1/2 inhibitor U0126.
The viability of control or MCMV-infected DCs after inhibi-
tion of the ERK pathway was not altered (Fig. 2 a).
Inhibition of PI3 kinase induced apoptosis in LPS-stimu-
lated DCs (Fig. 2 b). The viability of LPS-stimulated DCs
grown in the presence of 25 
 
 
 
M LY294402 decreased at a
rate similar to that observed for immature DCs. Thus, PI3
kinase activity is required for the survival of both immature
and LPS-stimulated DCs. Conversely, inhibition of PI3 ki-
nase did not affect the viability of MCMV-infected DCs
(Fig. 2 b).
 
Expression of Bim increases after growth factor 
withdrawal
 
We next sought to characterize the molecular events lead-
ing to apoptosis of DCs after growth factor withdrawal.
Given the role of Bcl-2 proteins in regulating apoptosis in-
duced by growth factor deprivation, we monitored the ex-
pression of Bcl-2 family members in DCs during apoptosis
induced by withdrawal of growth factor. No change in the
protein level of Bcl-2, Bcl-x
 
L
 
, or Bax was observed after
growth factor withdrawal at any of the time points tested
(Fig. 3 a). Similarly, no change in the expression of pro-
survival Bcl-w or Bfl-1/A1 protein was detected, whereas
expression of Mcl-1 was not detected in these cells (not de-
picted). An increase in the expression of Bim, a BH3 only
pro-apoptotic protein was observed (Fig. 3 a). Alternative
splicing of Bim gives rise to three variants (BimEL, BimL,
and BimS) each of which contains the BH3 domain and is
capable of functioning as a death inducer (O’Connor et al.,
1998). Bim activity is regulated at a posttranslational level
and, in healthy cells most Bim molecules are sequestered to
the microtubular dynein motor complex (Puthalakath et
al., 1999). Certain apoptotic stimuli result in translocation
of Bim to the mitochondria where the protein is able to
antagonize the function of pro-survival Bcl-2 molecules
(Puthalakath et al., 1999). Therefore, the proportion of
Bim protein localizing to mitochondria in DCs grown in
the presence or absence of growth factor was examined by
subcellular fractionation. As expected, very little Bim pro-
tein could be detected in the mitochondrial fraction of
cells grown in the presence of growth factor, whereas a sig-
nificant amount was observed when DCs were grown in
the absence of growth factor for 12 h (Fig. 3 b). These re-
sults are consistent with observations made in lymphocyte
and neuronal cultures, where Bim expression has been
found to be critical for the initiation of apoptosis after
growth factor withdrawal (Bouillet et al., 1999; Villunger
et al., 2000; Putcha et al., 2001; Shinjyo et al., 2001).
 
Protection from apoptosis correlates with increased 
expression of pro-survival Bcl-2 proteins
 
A number of reports have demonstrated that DC survival is
enhanced after activation induced by inflammatory signals,
or by T cell–derived factors, such as CD40L or TNF-related
activation-induced cytokine (Bjork et al., 1997; Wong and
Choi, 1997; Pirtskhalaishvili et al., 2000; Park et al., 2002).
Increased expression of Bcl-2 and/or Bcl-x
 
L
 
 in these cells
might explain these results (Bjork et al., 1997; Wong and
Choi, 1997; Pirtskhalaishvili et al., 2000; Park et al., 2002).
Therefore, we compared the expression of Bcl-2 family pro-
teins in immature, LPS-stimulated, and MCMV-infected
DCs by immunoblot analysis to determine whether alter-
ations in the expression of these proteins might explain the
observed inhibition of apoptosis. Stimulation of DCs with
LPS resulted in increased expression of the pro-survival Bcl-2
family members Bcl-x
 
L
 
 and Bfl-1/A1, whereas expression
of Bcl-2 and Bcl-w was not affected (Fig. 4). An increase in
the expression of Bim was also observed after LPS stim-
ulation (Fig. 4). The increased expression of pro-survival
Bcl-2 family proteins may allow these cells to tolerate the in-
creased expression of Bim (O’Connor et al., 1998). Although
MCMV infection of DCs had no effect on the expression of
Bcl-x
 
L
 
, an increase in Bfl-1/A1 and Bim protein expression
was observed (Fig. 4).
Figure 3. Withdrawal of growth factor from DCs leads to increased 
Bim expression. (a) Total cell lysates were prepared from uninfected 
immature D1 DCs grown in the presence or absence of growth 
factor for the indicated times. Cell lysates were resolved by SDS-PAGE, 
transferred to PVDF membrane, and immunoblotted with antibodies 
against the indicated proteins. (b) D1 DCs were grown in the presence 
or absence of growth factor for 8 h. Cells were subjected to isotonic 
lysis and mitochondrial (Mito) and cytoplasmic (Cyto) fractions 
isolated. Proteins were resolved by SDS-PAGE, transferred to PVDF 
membrane, and expression of the indicated proteins determined by 
immunoblot. White lines indicate that intervening lanes have been 
spliced out. 
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Bax is targeted to mitochondria in MCMV-infected DCs
 
MCMV infection might inhibit apoptosis by preventing the
mitochondrial dysfunction normally associated with the ap-
optotic process. A key event in mitochondrial dysfunction is
the translocation of Bax from the cytosol to the mitochon-
dria, where it facilitates the release of pro-apoptotic mole-
cules (Wang, 2001). Inhibition of cell death by Bcl-x
 
L
 
 has
been associated with its ability to inhibit the formation of
Bax clusters at the mitochondrial membrane (Nechushtan et
al., 2001). Given the observed increase in the expression of
Bcl-xL and/or Bfl-1/A1 in DCs that had become resistant to
apoptosis, we investigated the possibility that Bax transloca-
tion might be inhibited in these cells. Cellular fractionation
and immunoblot analysis were used to monitor the subcellu-
lar distribution of Bax in uninfected, LPS-stimulated, or
MCMV-infected DCs. As expected the majority of Bax pro-
tein localized to the cytoplasmic fraction of immature and
LPS-stimulated DCs grown in the presence of growth factor
(Fig. 5 a). Removal of the growth factor from immature
DCs resulted in translocation of Bax from cytoplasmic to
mitochondrial fractions, along with a concomitant increase
in the amount of cytochrome 
 
c
 
 that could be detected in the
cytoplasmic fraction (Fig. 5 a). Conversely, growth factor
withdrawal from LPS-stimulated DCs did not alter the sub-
cellular localization of Bax nor did it increase cytoplasmic
cytochrome 
 
c
 
 levels. Surprisingly, Bax was constitutively lo-
calized to the mitochondrial fraction in MCMV-infected
DCs, both in the presence and absence of growth factor. De-
spite the translocation of Bax to the mitochondrial fraction,
cytochrome 
 
c
 
 levels did not increase in the cytoplasm, sug-
gesting that mitochondrial integrity was not disrupted.
Bax was also constitutively associated with mitochondria in
Flt3L expanded DCs after MCMV infection (Fig. 5 b). To-
gether, these results indicate that in DCs MCMV inhibits
apoptosis after Bax translocation to the mitochondria.
 
Mitochondrial membrane potential (
 
  
 
m) is 
maintained in MCMV-infected DCs
 
The translocation of Bax from the cytosol to the mitochon-
dria occurs at an early stage of the apoptotic pathway (Hsu
et al., 1997; Wolter et al., 1997). However, Bax has also
been reported to be in peripheral association with the mito-
chondria in healthy cells (Goping et al., 1998; Desagher
et al., 1999). Regardless of its subcellular localization in
healthy cells, after an apoptotic stimulus, Bax undergoes a
conformational change and integrates into the mitochon-
drial membrane. Thus, we tested whether the Bax protein
localized to the mitochondria of MCMV-infected DCs was
merely peripherally associated with mitochondrial mem-
branes. Surprisingly, the Bax protein localized to the mito-
chondria of MCMV-infected DCs was resistant to alkaline
extraction, indicating that in infected DCs Bax integrates
Figure 4. MCMV infection or LPS stimulation of DCs affects the 
expression of Bcl-2 family members. Total cell lysates were prepared 
from uninfected, LPS-stimulated, or MCMV-infected D1 DCs, resolved 
by SDS-PAGE and transferred to PVDF membrane. Membranes 
were immunoblotted with the indicated antibodies.
Figure 5. Bax localizes to the mitochondria in MCMV-infected DCs. 
Mitochondrial (Mito) and cytoplasmic (Cyto) fractions were isolated 
from control or MCMV-infected (a) D1 DCs or (b) Flt3L expanded 
DCs. Lysates were separated by SDS-PAGE, transferred to PVDF 
membrane, and immunoblotted with the indicated antibodies. 
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into the mitochondrial membrane (Fig. 6 a). Integration
of Bax into the mitochondrial membrane is normally as-
sociated with the loss of 
 
  
 
m. 
 
  
 
m was examined in
control and MCMV-infected DCs using MitoTracker red
CMXRos, a dye whose accumulation in mitochondria de-
pends on mitochondrial transmembrane potential (Marzo et
al., 1998). Uninfected and MCMV-infected DCs accumu-
lated the MitoTracker dye to a similar extent (Fig. 6 b). The
specificity of the MitoTracker staining was confirmed by in-
cubating DCs with the mitochondrial uncoupler carbonyl
cyanide m-chlorophenylhydrazone (CCCP). Exposure of
control and MCMV-infected DCs to CCCP resulted in a
significant reduction in MitoTracker signal. Together, these
results indicate that the mitochondria of MCMV-infected
DCs maintain normal membrane potential despite the tight
association of Bax with mitochondrial membranes.
 
Bax oligomerization occurs in the absence of
NH
 
2
 
-terminal epitope exposure
 
In addition to changes in the subcellular localization of
Bax, exposure of an occluded NH
 
2
 
-terminal epitope and
oligomerization have been correlated with apoptosis. The
NH
 
2
 
-terminal conformation of Bax was assessed using the
conformation-specific 6A7 antibody. Uninfected or MCMV-
infected DCs were grown in the presence or absence of
growth factor for 8 h, and cell lysates prepared in the pres-
ence of CHAPS detergent. As expected, the 6A7 antibody
could not efficiently detect Bax from control DCs (unin-
fected, plus growth factor), whereas Bax in the “active” con-
formation was readily detected in DCs undergoing apop-
tosis (uninfected, no growth factor; Fig. 7 a). In contrast, in
MCMV-infected DCs the 6A7 antibody failed to detect
Bax, even in the absence of growth factor (Fig. 7 a).
Size exclusion chromatography was then used to charac-
terize the oligomerization state of Bax. Mitochondria from
control or MCMV-infected DCs, grown in the presence or
absence of growth factor, were isolated by differential cen-
trifugation. Mitochondrial proteins were solubilized using
2% CHAPS and the extracts analyzed by gel filtration. In
healthy DCs Bax eluted as a monomer, with an apparent
molecular mass of 
 
 
 
20 kD (Fig. 7 b). Removal of growth
factor from uninfected DCs resulted in Bax forming com-
plexes with molecular masses 
 
 
 
67 kD. Surprisingly, the
majority of Bax in MCMV-infected cells was contained in
high molecular weight complexes, even before growth fac-
tor withdrawal (Fig. 7 b). These results demonstrated that
MCMV infection of DCs leads to the oligomerization of
Bax at the mitochondria; however, exposure of the NH
 
2
 
-ter-
minal epitope, normally observed during the induction of
apoptosis, is inhibited as a result of MCMV infection.
Knockout studies have demonstrated a redundant role for
Bax and Bak, with either protein sufficient to induce apop-
Figure 6.   m is not altered despite 
Bax integration to mitochondrial mem-
branes. (a) Mitochondrial fractions 
prepared from uninfected or MCMV-
infected D1 DCs were incubated in
0.1 M Na2CO3, pH 11.5, and centrifuged
at 100,000 g for 45 min to yield super-
natant (S) and pellet (P) fractions con-
taining alkali-sensitive and -resistant
proteins, respectively. Samples were 
resolved by SDS-PAGE, transferred to 
PVDF membrane, and immunoblotted 
with the indicated antibodies. (b)   m 
was analyzed in uninfected or MCMV-
infected DCs labeled with MitoTracker 
red CMXRos in the presence or absence 
of the mitochondrial uncoupler CCCP,
as indicated. Dual staining with the 
nuclear dye Hoechst 33258 allows 
visualization of all the cells in the field. 
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tosis in a variety of cell types (Lindsten et al., 2000). Like
Bax, induction of apoptosis results in a conformational
change to the NH
 
2
 
 terminus of Bak and its oligomerization.
Exposure of the Bak NH
 
2
 
-terminal epitope after MCMV in-
fection could not be assessed because appropriate mouse re-
agents do not exist. Gel filtration analysis was used to deter-
mine the oligomerization status of Bak. In healthy DCs Bak
eluted over a broad range (Fig. 7 c), implying that mono-
meric and oligomeric forms of Bak are present in normal
cells, a result consistent with previous reports (Antonsson et
al., 2001). After induction of apoptosis in DCs a small
change in the elution profile of Bak was observed with a
larger proportion of high molecular weight Bak complexes
being detected. In MCMV-infected DCs Bak was predomi-
nantly contained within high molecular weight complexes
even before growth factor withdrawal (Fig. 7 c). Thus,
MCMV infection of DCs results in the oligomerization of
both Bax and Bak.
 
MCMV M36, M37, and M45 do not interfere with Bax 
function
 
Three MCMV proteins (M36, M37, and M45) have been
ascribed possible anti-apoptotic functions (Goldmacher et
al., 1999; Brune et al., 2001; Skaletskaya et al., 2001; Mc-
Cormick et al., 2003), and thus represent potential candi-
dates for the inhibition of Bax function we observed after
MCMV infection. To test the relevance of these proteins,
Figure 7. Bax and Bak elute as high molecular weight oligomers in 
MCMV-infected DCs, but exposure of a Bax NH2-terminal epitope 
is inhibited. (a) MCMV-infected or uninfected control D1 DCs were 
grown in the presence or absence of growth factor for 8 h and total 
cell lysates prepared using 2% CHAPS lysis buffer. Bax protein was 
immunoprecipitated using the 6A7 conformation-specific antibody. 
Precipitated proteins were resolved by SDS-PAGE and detected by 
immunoblot. (b and c) Uninfected or MCMV-infected DCs were 
grown in the presence or absence of growth factor for 12 h. 
Mitochondria were isolated by differential centrifugation, treated with 
2% CHAPS lysis buffer, and solubilized proteins were separated by 
gel filtration. The indicated fractions were resolved by SDS-PAGE 
and immunoblotted with antibodies against (b) Bax and (c) Bak.
Figure 8. Candidate MCMV anti-apoptotic proteins do not bind 
Bax or inhibit apoptosis. Flag-tagged M36, M37, and M45 MCMV 
viral ORFs were transiently transfected into COS cells. (a) Cells were 
lysed in the presence of 2% CHAPS and Flag-tagged proteins immuno-
precipitated. Immunoprecipitated proteins were resolved by SDS-
PAGE and immunoblotted with anti-Bax specific antibody. The 
expression of the Flag-tagged constructs was confirmed by immuno-
blotting of total cell lysates. White lines indicate that intervening 
lanes have been spliced out. (b) Cells were grown in the presence 
(shaded bars) or absence (white bars) of staurosporine (250 nM) 
for 18 h and the number of viable cells counted. Data represent the 
mean   SD, n   4. 
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we determined their ability to interact with Bax and to pre-
vent apoptosis induced via the mitochondrial pathway. The
viral ORFs were transfected into COS-7 cells and interac-
tion with Bax determined by coimmunoprecipitation. Bax
did not interact with either M36, M37 or M45 (Fig. 8 a).
Furthermore, overexpression of these MCMV proteins did
not protect from staurosporine-induced apoptosis (Fig. 8 b).
The inability of the viral proteins to interact with Bax and
prevent apoptotic cell death was confirmed by transfection
studies in murine fibroblasts (not depicted).
 
Discussion
 
Interference with DC function is a strategy used by a num-
ber of viruses to disarm the host immune response. Here, we
have investigated the effects of MCMV on the viability of
DCs, a primary target of infection in vivo (Andrews et al.,
2001). MCMV infection protects DCs from apoptosis in-
duced by growth factor withdrawal. Protection from apop-
tosis is also observed in DCs after bacterial encounter. Al-
though the PI3 kinase pathway is essential for the protection
induced by bacterial encounter, it is not required for the
protection induced by MCMV infection suggesting that sig-
nal transduction pathways other than those affected during
bacterial infection are targeted by the virus. Characterization
of the molecular events associated with DC apoptosis in-
duced by growth factor withdrawal indicated that Bim ex-
pression is increased, prompting us to analyze the expression
of Bcl-2 family proteins in LPS-stimulated and MCMV-infected
DCs. Our finding that expression of Bcl-x
 
L
 
 and Bfl-1/A1
was increased after LPS stimulation provides a mechanism
to explain the anti-apoptotic effects of LPS stimulation.
Typically, increased expression of pro-survival Bcl-2 pro-
teins inhibits the translocation of Bax to the mitochondria,
thus, preventing mitochondrial dysfunction (Marsden and
Strasser, 2003). Indeed, no significant translocation of Bax
to mitochondria was observed in LPS-stimulated DCs after
growth factor withdrawal. Similar observations have recently
been reported using GM-CSF expanded DCs, where alter-
ations in Bcl-2 protein expression were proposed to act as a
molecular timer regulating DC life span (Hou and Van Par-
ijs, 2004). In contrast, despite the fact that Bfl-1/A1 expres-
sion is increased in MCMV-infected DCs, in these cells Bax
predominantly localized to mitochondria. These findings
provide compelling evidence that different molecular mech-
anisms protect DCs from apoptosis after LPS stimulation
and MCMV infection.
The significance of Bax and Bak to the initiation of apop-
tosis is underscored by the finding that mice deficient
for  both proteins display multiple developmental defects
(Lindsten et al., 2000). The key event in apoptosis medi-
ated through mitochondrial dysfunction is a conformational
change in Bax and Bak and the formation of high molecular
weight complexes (Hsu et al., 1997; Nechushtan et al.,
2001; Sundararajan and White, 2001). After MCMV in-
fection, Bax was found in tight association with the mito-
chondrial membrane, and both Bax and Bak were in an
oligomerized form. Despite both Bax and Bak displaying
characteristics typically observed during apoptosis, 
 
  
 
m
was not affected, nor was cytochrome 
 
c
 
 released into the cy-
toplasm. Importantly, a conformational change which ex-
poses a constitutively occluded epitope at the NH
 
2
 
 terminus
of Bax, and which normally occurs during apoptosis, was
not observed in MCMV-infected DCs. Translocation of Bax
to mitochondria and formation of Bax complexes without a
loss of mitochondrial integrity were reported in a taxol-resis-
tant cell line (Makin et al., 2001). The percentage of taxol-
resistant cells which had oligomerized Bax, and how much
Bax protein was in this conformation was difficult to deter-
mine, and indeed the majority of Bax in these cells was
monomeric (Makin et al., 2001). In our MCMV-infected
DC cultures all the Bax protein was oligomerized, despite the
complete resistance to apoptosis. The exposure of the consti-
tutively occluded NH
 
2
 
-terminal epitope of Bax observed in
taxol-resistant cells (Makin et al., 2001), did not occur in
MCMV-infected DCs. Our findings raise the interesting
possibility that MCMV sequesters Bax and Bak in oligo-
meric complexes which are structurally distinct from those
required to induce apoptosis. Alternatively, additional pro-
teins may be required to cooperate with Bax/Bak oligomers
to induce mitochondrial permeabilization.
Thus, MCMV infection reveals the existence of a check-
point in the Bcl-2–regulated apoptotic pathway after trans-
location/oligomerization of Bax and Bak. This checkpoint is
specifically targeted by MCMV to inhibit apoptosis in DCs.
Given the importance of Bax/Bak in the apoptotic process
it is not surprising that a number of viruses have evolved
strategies to interfere with the function of these proteins.
Several viruses encode Bcl-2 homologues that appear to in-
terfere with apoptosis by directly binding to Bax/Bak and
antagonizing their function (Cuconati et al., 2002). The
best characterized of these is the E1B 19K protein of adeno-
virus (Perez and White, 2000). CMVs do not encode se-
quence homologues of Bcl-2, suggesting that this family of
viruses has evolved alternative strategies to interfere with
Bax/Bak functions. The product of the HCMV gene UL37
encodes a mitochondria-localized death suppressor termed
vMIA (Goldmacher et al., 1999; Goldmacher, 2002). Re-
cent reports have demonstrated that vMIA functions by se-
questering Bax at the mitochondrial membrane in an inac-
tive complex (Arnoult et al., 2004; Poncet et al., 2004).
Although M37, the MCMV homologue of UL37, would
seem an ideal candidate for mediating the observed inhibi-
tion of Bax function in MCMV-infected DCs, it should be
noted that the homology between M37 and UL37 is re-
stricted to the region encoding UL37 exon 3. Both anti-apop-
totic and mitochondrial localizing functions of UL37 have
been mapped to exon 1, a region lacking obvious sequence
homology in the MCMV genome (Rawlinson et al., 1996;
Goldmacher, 2002). Indeed, we were unable to demonstrate
an association between M37 and Bax, and overexpression of
M37 in COS-7 or NIH-3T3 cells did not inhibit apoptosis
induced by staurosporine treatment. Similarly, coimmuno-
precipitation experiments showed that Bax does not associ-
ate with either M36 or M45, the other known anti-apop-
totic proteins encoded by MCMV.
Because MCMV infection of DCs results in changes to
Bax similar to those induced by vMIA, we hypothesize that a
functional homologue of the HCMV vMIA is encoded by
MCMV. Identification of this protein is the focus of our on- 
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going studies. Unlike vMIA, which does not bind Bak or in-
hibit its function (Arnoult et al., 2004), infection of DCs
with MCMV resulted in the oligomerization of both Bax
and Bak. A possible explanation for this observation is that
the putative MCMV vMIA homologue can interact with
both Bax and Bak; alternatively, MCMV might encode an
additional proteins which specifically interferes with Bak
function. Finally, because activation of Bak in some cells has
been shown to require Bax activation (Arnoult et al., 2004),
an alternative possibility is that interference with Bax func-
tion is sufficient to prevent apoptosis in DCs.
In conclusion, we have shown that CMV interferes with
apoptosis in DCs, cells that are major targets of infection and
viral replication both in vitro and in vivo. The ability of
MCMV to increase the life span of DCs confers the virus a
significant survival advantage, because in these cells MCMV
replicates to high titres for long periods of time (Andrews et
al., 2001). A further exciting outcome of our studies is the
clear definition of a checkpoint in the Bcl-2–regulated apop-
totic pathway after Bax/Bak oligomerization, but before mi-
tochondrial disruption. Our results provide unequivocal evi-
dence that translocation, integration, and oligomerization of
Bax at the mitochondrial membrane, generally thought to
represent a terminal commitment to cell death, are in fact not
sufficient to force cells to die, because in MCMV-infected
DCs these events occur, but the cells remain viable. Analysis
of viral infections has provided many novel and important
clues about complex cellular processes and pathways. Further
elucidation of the mechanism used by MCMV to interfere
with mitochondrial functions will undoubtedly contribute
important insights into the regulation of apoptosis.
 
Materials and methods
 
Cell lines and reagents
 
Mouse embryonic fibroblasts were cultured in minimal essential medium
(GIBCO BRL) supplemented with neonatal calf serum (GIBCO BRL). D1
DCs were derived from murine splenic DCs and maintained in vitro as
growth factor–dependent immature DCs (Winzler et al., 1997). D1 DCs
were cultured in complete Iscove’s modified Dulbecco’s medium (IMDM;
Sigma-Aldrich) containing 10% heat inactivated FBS (GIBCO BRL); 100
IU/ml penicillin and 100 
 
 
 
g/ml streptomycin (Amersham Biosciences and
Upjohn); 2 mM 
 
L
 
-glutamine and 50 
 
 
 
M 2-mercaptoethanol and supple-
mented with 30% CM containing 10–20 ng/ml GM-CSF (Winzler et al.,
1997). Flt3L expanded DCs were generated from the bone marrow of
C57BL/6 mice as described previously (Brasel et al., 2000). COS-7 cells
were cultured in DME (GIBCO BRL), 10% FBS, and transfected by the
standard DEAE-dextran method with 15 
 
 
 
g of each relevant construct. The
MCMV viral ORFs m36, m37, and m45 were cloned into pCDNA3 in
frame with a COOH terminus FLAG.
 
Preparation and purification of MCMV stocks
 
Mouse embryonic fibroblasts were infected with MCMV-K181-Perth sali-
vary gland passaged stocks with an MOI of 0.05 for 1 h at 37
 
 
 
C. Cells were
monitored daily for evidence of cytopathic effect and the supernatant re-
moved when 100% cpe was observed. Supernatants were filtered through
0.45-
 
 
 
m filters and centrifuged at 35,000 
 
g
 
 for 2 h at 4
 
 
 
C. The supernatant
was removed, and the viral pellet resuspended in ice-cold medium, ali-
quoted, and stored at 
 
 
 
180
 
 
 
C. Viral titers were determined on embryonic
fibroblasts as described previously (Farrell et al., 1997).
 
Induction and detection of apoptosis
 
Apoptosis was induced in D1 or Flt3L expanded DCs by washing cells
twice in serum-free medium. D1 DCs were reseeded in complete IMDM
without R1 CM, whereas Flt3L DCs were reseeded in IMDM/1% FCS. PI3
kinase and MEK1/2 activity was inhibited with LY294002 (Calbiochem) and
U0126 (Cell Signaling Technology), respectively. Apoptosis was assessed
by staining cells with annexin V-FLUOS (Roche) according to the manufac-
turer’s recommendation and cells analyzed on a FACSCalibur (Becton
Dickinson). Caspase activity was determined using the caspase-3 substrate
Ac-DEVD-pNA (Calbiochem) according to the manufacturer’s instructions.
Apoptosis was induced in transfected COS-7 cells by staurosporine treat-
ment (250 nm, 18 h). Viability was assessed by trypan blue exclusion.
 
Antibodies
 
The following antibodies were used for this work: anti-Grb2 (clone C-23)
obtained from Santa Cruz Biotechnology; anti–Bfl-1/A1 (clone 78616.11)
obtained from R&D Systems; anti–Cox IV (clone 20E8) obtained from Mo-
lecular Probes; anti–cytochrome 
 
c
 
 (7H8.2C12), anti–Bcl-x (clone 44), and
anti-Bax (6A7) obtained from BD Biosciences; anti-Bax (clone 5B7) ob-
tained from Sigma-Aldrich; and anti-Bax and anti-Bak obtained from Up-
state Biotechnology. The anti–Bcl-2 (clone 3F11), anti-Bim (clone 14A8),
and anti–Bcl-w antibodies were gifts from D. Wang and L. O’Reilly (Walter
and Eliza Hall Institute, Melbourne, Australia). Anti–mouse and anti–rabbit
peroxidase conjugates were purchased from Amersham Biosciences; the
anti–rat and anti–Armenian hamster peroxidase conjugates were obtained
from Jackson ImmunoResearch Laboratories.
 
Preparation of cell lysates and subcellular fractionation
 
Total cell lysates were prepared by resuspending cells in Triton X-100 lysis
buffer (150 mM NaCl, 10 mM Tris, pH 7.4, 1% Triton X-100, 1
 
 
 
 complete
protease inhibitors [Roche]) and incubating on ice for 30 min. Nuclei and
cell debris was removed by centrifugation (1,000 g for 5 min) and protein
concentration determined using a Micro BCA assay kit (Pierce Chemical
Co.). Cytoplasmic and mitochondrial fractions were prepared by resus-
pending 10
7 cells in 500  l isotonic lysis buffer (210 mM mannitol, 70 mM
sucrose, 20 mM Hepes, pH 7.2, 10 mM KCl, 1.5 mM MgCl2, 1 mM EGTA,
1  complete protease inhibitors) and passing the sample through a G27
needle 30 times. The resulting sample was centrifuged at 1,500 g for 5 min
to remove nuclei and unbroken cells. The supernatant was subsequently
centrifuged at 14,000 g for 10 min. The pellet, containing mitochondria
was resuspended in Triton X-100 lysis buffer, while the supernatant was
centrifuged at 100,000 g for 45 min at 4 C with the resulting supernatant
used as the cytoplasmic fraction.
Alkali extraction of mitochondria
Mitochondria from healthy or apoptotic cells were isolated as described
above and resuspended in freshly prepared 0.1 M NaCO3, pH 11.5, and
incubated for 20 min on ice. Mitochondrial membranes were pelleted by
centrifugation (100,000 g for 2 h at 4 C). The resulting pellet (alkali–resis-
tant fraction) was resuspended in Triton X-100 lysis buffer, while the super-
natant contained alkali–sensitive proteins.
Immunoblotting
Protein samples were resolved on 4–12% Bis-Tris gradient gels (Novex)
and transferred to PVDF plus membrane (Osmonics). Immunodetection
was performed using the appropriate peroxidase-conjugated secondary an-
tibody and ECL detection reagent (Amersham Biosciences). Equal loading
of lanes was confirmed by Grb2 or Cox IV immunoblot.
Confocal microscopy
Analysis of   m was performed by resuspending cells (3 x10
5 cells/ml) in
medium containing 300 nM MitoTracker red CMXRos in the presence or
absence of 50  M CCCP for 20 min at 37 C. Cells were then washed in
medium twice and plated onto silane-(ICN Biomedicals)-coated coverslips
and incubated at 37 C for 20 min. Cells were fixed in 3.7% PFA (37 C for
15 min), and washed twice in PBS. Cells were permeabilized with PBS/
0.2% Triton X-100 and stained with 2  M Hoechst 33258 to visualize nu-
clei and mounted. All analysis was performed on an MRC 1000/1024 UV
laser scanning confocal microscope (Bio-Rad Laboratories) with a 40  ob-
jective (NA 1.3; Nikon) and images saved as Biorad.PIC files. Subsequent
analysis was performed using Adobe Photoshop v. 7.0.
Gel filtration
Gel filtration was performed at 4 C using Toyopearl HW-65F resin (Tosoh
Bioscience) equilibrated in column buffer (25 mM Hepes-NaOH, pH 7.5,
300 mM NaCl, 200  M DTT, 2% CHAPS). The column was calibrated using
ferritin (440 kD), BSA (67 kD), and trypsin inhibitor (20.1 kD). The void vol-
ume of the column was determined using blue dextran. Mitochondria were
isolated by differential centrifugation as outlined above and solubilized us-
ing CHAPS lysis buffer (150 mM NaCl, 25 mM Hepes, pH 7.5, 2% CHAPS,
1  complete protease inhibitors). The sample was then centrifuged at836 The Journal of Cell Biology | Volume 166, Number 6, 2004
21,000 g for 20 min to remove insoluble material. Samples of 500  l were
loaded onto the column and the eluate was monitored at 280 nm. Fractions
of 25 drops (680  l) were collected and aliquots analyzed by immunoblot.
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